JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...
Healthcare Analysts discus what’s new and what is on the horizon for Non-Tuberculosis Mycobacteria Lung Disease (relevant companies ANTX INSM ...
JMP Securities has reaffirmed its Market Outperform rating and a price target of $41.00 on Exelixis stock (NASDAQ:EXEL), aligning with the broader analyst consensus that sees upside potential.
JMP Securities analyst Steven DeLaney lowered the firm’s price target on Redwood Trust (RWT) to $8 from $9 and keeps an Outperform rating on ...
On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...
Orchid Island Capital Inc (ORC) stock saw a decline, ending the day at $7.94 which represents a decrease of $-0.08 or -1.00% from the prior close of $8.02. The stock opened at $8.01 and touched a low ...
JMP Securities restated their market outperform rating on shares of BlackLine (NASDAQ:BL – Free Report) in a research report released on Wednesday morning,Benzinga reports. The firm currently has a ...
JMP Securities restated their market outperform rating on shares of Churchill Downs (NASDAQ:CHDN – Free Report) in a report ...
Benchmark believes that Roku can benefit meaningfully from establishing partnerships with other platforms and further ...
JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending antitrust litigation.The firm believes the Department of Justice case ...
JMP Securities initiated coverage of Context Therapeutics (CNTX) with an Outperform rating and $4 price target Context is a $97.8M market cap clinical-stage biotechnology company focused on ...
JMP Securities analyst Silvan Tuerkcan initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $15 price target Solid is a clinical-stage biotechnology company focused on ...